12 Two forms mia, in which sCD23 levels can be up to 500-fold higher of 45-kD CD23 exist, CD23a and CD23b, which differ only than normal and the levels of sCD23 correlate with the cliniin their cytosolic domains 13 ; the former is constitutively excal stage of the disease. 25 Thus, there is strong circumstantial pressed by B cells, and the latter is induced by exposure of evidence that sCD23 is both biologically active and clinically the cells to interleukin-4 (IL-4).
T hereafter as sCD23. 17 Thus, sCD23 has been shown to act as an autocrine growth factor in some Epstein-Barr virus HE HUMAN leukocyte differentiation antigen CD23 is a 45-kD type-II transmembrane glycoprotein, expressed on numerous hematopoietic lineage cells, which (EBV)-transformed mature B-cell lines 18 and as a differentiafunctions as a low-affinity receptor for IgE.
1-4 The CD23 tion factor for prothymocytes 19 and also to prevent apoptosis molecule is a member of the C-type (Ca 2/ -dependent) lectin of germinal centre B centrocytes, 20 possibly via induction of family, and contains an a-helical coiled-coil stalk region bcl-2 expression. 21 The putative pleiotropic cytokine activibetween the extracellular lectin domain and the transmemties of sCD23 are linked to a domain distinct from that brane region, which is believed to facilitate oligomerization involved in IgE binding. 22 Elevated levels of sCD23 have of membrane-bound CD23 to trimers. 5, 6 Membrane-bound been found in a range of clinical conditions such as rheuma-CD23 has roles in IgE binding, 7,8 regulation of IgE synthetoid arthritis, 23 allergy, 24 and B-chronic lymphocytic leukesis, 9 cell adhesion 10,11 and antigen presentation. 12 Two forms mia, in which sCD23 levels can be up to 500-fold higher of 45-kD CD23 exist, CD23a and CD23b, which differ only than normal and the levels of sCD23 correlate with the cliniin their cytosolic domains 13 ; the former is constitutively excal stage of the disease. 25 Thus, there is strong circumstantial pressed by B cells, and the latter is induced by exposure of evidence that sCD23 is both biologically active and clinically the cells to interleukin-4 (IL-4).
14 CD23 is usually expressed important. at the mature B-cell stage, mostly on activated cells, although
The reported receptors for CD23 are CD21, 10 CD11b, and some malignant pre-B cells from acute lymphoblastic leukeCD11c. 26 CD21, a receptor for the C3d, C3g, and iC3b commia patients can be induced to express CD23 after stimulaplement proteins, interferon-a and also EBV, 27 is a 145-kD tion with IL-4. 15 glycoprotein expressed on B lymphocytes, some T lymphoThe membrane form of CD23 undergoes proteolysis, givcytes, follicular dendritic cells and pharyngeal epithelial ing rise to soluble CD23 molecules of molecular weights 37 cells. 27, 28 The CD23/CD21 interaction involves the C-type kD, 33 kD, 29 kD, 25 kD, and 16 kD. All fragments possess lectin activity of CD23, 29 and CD21 and CD23 can therefore the lectin binding domain and, with the exception of the 16- be regarded as a pair of adhesion molecules. 10, 11, 30 Since kD fragment, retain the ability to bind IgE.
1, 16 A range of CD21 is expressed by B and T cells and by follicular denother cytokine activities have been attributed to soluble dritic cells, the ability of sCD23 to prevent apoptosis in CD23 species, particularly to the 25-kD form referred to germinal centre cells 20 has been postulated to occur via CD21. CD11b-CD18 and CD11c-CD18 are members of the b 2 integrin family of adhesion proteins, and have recently 1b, IL-6, and tumor necrosis factor-a, indicating a physio- 26 Both 45-kD full-length and 25-kD sCD23 zol B, according to the manufacturer's instructions. Briefly, 10 6 to species were affinity purified as previously described.
33,34 The Rb55 10 7 cells were pelleted, washed in ice-cold PBS, lysed by addition rabbit antiserum was raised against the 25-kD sCD23 polypeptide of 0.2 to 2 mL RNAzol B. One-tenth volume of chloroform was (residues 150-321) expressed in E coli, and was employed as an added, the tube shaken vigorously for 15 seconds and left on ice for affinity-purified IgG fraction. 29 This reagent neutralizes the activity 5 minutes, and then centrifuged at 12,000g at 4ЊC for 15 minutes. of CD23 in assays of human B-cell IgE production in vitro, and also
The aqueous phase was removed, an equal volume of ice-cold isoproblocks antigen-specific IgE responses in vivo when administered panol added and the RNA precipitated at 020ЊC overnight. intravenously to rats.
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Reverse transcriptase-polymerase chain reaction (RT-PCR).
For PCR amplification, a GeneAMP RNA PCR kit (Perkin Elmer Cetus,
The SMS-SB Cell Line
Beaconsfield, UK) was used per the manufacturer's instructions. Random hexamers (2.5 mmol/L) were used in the reverse transcripThe SMS-SB cell line is a human pre-B cell-like acute lymphocytic leukemia cell line, isolated from a female patient in 1981. amplification step employed Amplitaq DNA polymerase (Perkin Elmer Cetus) plus appropriate primers at 0.15 mmol/L. PCR amplificaConsistent with an acute lymphocytic leukemia (ALL) classification, SMS-SB cells contain cytoplasmic m chains but are surface Ig negation was performed in a Perkin Elmer Cetus DNA thermal cycler as follows: 2 minutes at 94ЊC for 1 cycle; 1 minute at each of 94ЊC, tive, negative for CD10 (CALLA), and EBV-nuclear antigen expression, and do not display any of the chromosomal translocations 55ЊC and 72ЊC for 35 successive cycles; 10 minutes at 72ЊC followed by storage at 5ЊC until retrieval. commonly associated with lymphoproliferative tumors 31 ; the cells show a degree of overexpression of the c-fos proto-oncogene. 32 The Hybridization procedures. RT-PCR reaction products were electrophoresed on 0.8% (wt/vol) agarose/tris-borate-EDTA (TBE) noncells adapted spontaneously to culture and are readily propagated in serum-free and protein-free media.
denaturing 
SMS-SB Cells
(at 10 mg/mL, unless otherwise stated) for 1 hour at 4ЊC before the liposomes were added to the cells.
To determine if SMS-SB cells were dying by apoptosis
Staining of bcl-2 in permeabilized cells. SMS-SB cells were
and that sCD23 acted to prevent apoptosis, cells were cul- ( Fig 2) . Cells cultured at normal cell density showed few
The cells were treated with 1 mg of anti-bcl-2 monoclonal antibody apoptotic characteristics (Fig 2A) whereas cells cultured at in a final volume of 100-mL SBP for 20 minutes on ice, before low cell density (Fig 2B) exhibited a more spread morphol- were undergoing apoptosis, two-laser flow cytometric analyCells were harvested and washed as noted above and, after instrument settings were adjusted for forward and side scatter using unsis of SMS-SB cells harvested after 24 hours of culture at stained cells, the test samples were analyzed. The cells were stained normal or at low cell density either alone or in the presence with freshly-prepared solutions of propidium iodide (20 mL of a 50 of sCD23 or IL-4 was performed (Fig 3) . The cells were mg/mL solution in PBS) and Hoechst 33342 (100 mL of a 10 mg/ stained with propidium iodide and Hoechst 33342 and, after mL solution) for 1 minute before collection of data from 10,000 gating on the basis of scatter parameters, analyzed by twocells on a dual laser Coulter Elite flow cytometer. In all experiments laser flow cytometry. In cultures propagated at normal cell cell debris was excluded by electronic gating. density (Fig 3A) , approximately 90% of the cells were routinely located in the lower left quadrant of the dot-plots, . These values contrast sharply SMS-SB cells display a marked density-dependence for survival. 36 Thus, plating the cells at high cell density (Ç5 1 with the values for cells cultured at low cell density ( Fig  3B) where the number of viable cells was 68.3% and the 10 5 /mL) gives cultures which grow rapidly, while plating at lower cell densities (°5 1 10 4 /mL) results in cultures in number of late apoptotic cells was approximately 25%. Inclusion of IL-4 in these cultures (Fig 3D) mately 65%, and there was a sizeable population of dead SB cells into apoptosis under low cell density culture conditions. cells in cultures containing IL-4. However, the presence of sCD23 in the low cell density cultures (Fig 3C) resulted in sCD23 Influences bcl-2 Expression in SMS-SB Cells restoration of the number of viable cells in the culture to approximately 90% (89.1% in this example), and a reduction Expression of bcl-2 in SMS-SB cells was determined by immunostaining of bcl-2 protein and propidium iodide stainof late apoptotic cells to 6.3% of the culture, values which are essentially identical to those observed for normal cell ing of DNA content of permeabilzed SMS-SB cells following a variety of culture conditions (Fig 4) . Flow cytometric density cultures. The capacity of sCD23 to block apoptosis in low cell density cultures was concentration dependent; analysis of normal cell density cultures revealed a strong G1 peak (Fig 4A) , with a significant proportion of the cells in thus 10 ng/mL sCD23 resulted in approximately 12% of the cells scoring as late apoptotic compared with 6% when 100 S or G2/M phases, and greater than 97% of the cells scoring positive for bcl-2 expression. In contrast, cells from the low ng/mL sCD23 was included in the cultures (data not illustrated). The data indicate that sCD23 prevents entry of SMScell density culture ( Fig 4B) were mainly in a pre-G1 peak AID Blood 0013 / 5h38$$$241 06-02-97 10:41:47 blda WBS: Blood
For personal use only. on October 27, 2017. by guest www.bloodjournal.org From with weak staining for bcl-2. However, in the presence of sCD23 (Fig 4C) , there was a restoration of the cell cycle profile characteristic of asynchronously growing cells, and strong bcl-2 staining was observed in all phases of the cell cycle; in the example shown, 92.2% of the cells were bcl-2 / . These results suggest that sCD23 treatment of low cell density cultures of SMS-SB cells may sustain bcl-2 expression and prevent apoptosis.
SMS-SB Cells Do Not Express CD23
The expression of CD23 by SMS-SB cells was examined to address the possibility that CD23 was acting on SMS-SB cells in an autocrine manner, as has been shown for some EBV-transformed B-cell lines. 18 Flow cytometric analysis showed that SMS-SB cells had no CD23 on their surface but SKW cells (a mature human B-cell line) had readily detectable levels of CD23 (data not shown). RT-PCR was trophoresed and detected by Southern blotting (Fig 5) . Ramos and SKW both generated strong signals of 256 bp. No signals were detected using SMS-SB, Jijoye, or keratinocyte 
org From
RNA and there was no product from a reaction performed with no template RNA. Transcripts of c-fos were readily detectable in SMS-SB cells propagated under either proteinfree or serum-supplemented culture conditions (data not shown). Figure 5 also indicates that SMS-SB cells do not express any RNA for CD23 when cultured in protein free media or in medium supplemented with 10% serum. These data negate the hypothesis that SMS-SB cells express CD23 and utilize this cytokine in an autocrine loop to prevent apoptosis.
SMS-SB Cells Do Not Express Known CD23 Receptors
The data of Figs 1 through 4 show that sCD23 exerts a biological effect on SMS-SB cells raising the question of which CD23 receptor mediates this biological effect. The expression of known CD23 receptors by SMS-SB cells was assessed by flow cytometry as shown in Fig 6. SMS-SB cells and SKW cells were stained with FITC-labeled MoAb to each of CD11a, CD11b, and CD11c, and the data of Fig 6, A through C, respectively, clearly illustrate that while SKW cells express high levels of all three CD11 species, the level of staining of SMS-SB cells was superimposable on the autofluorescence profile for SMS-SB cells. Thus, SMS-SB cells do not express any of the CD11a, CD11b, or CD11c markers on their surface. Staining with FITC-anti-CD18 ( Fig  6D) illustrates that SMS-SB cells also lack this component of the b 2 integrin complex. Figure 6E shows a flow cytometric analysis of CD21 expression by SMS-SB cells in comparison with controls of the mature B-cell lines, Daudi, and Ramos. Daudi cells were strongly positive for CD21 expression whereas Ramos were only weakly positive. SMS-SB cells were negative for expression of CD21 at their surface. Neither SMS-SB cell cultures propagated in protein-free media nor those cultured in serum-supplemented media had detectable levels of Poly A / RNA for CD21 and no CD21 transcripts were detected by RT-PCR (data not illustrated). The data are consistent with the hypothesis that SMS-SB cells possess a receptor for CD23 distinct from CD21 and the CD11 family members.
Specific Binding of CD23-Containing Liposomes to SMS-SB Cells
Since SMS-SB cells do not express any of the currently characterized receptors for CD23 (CD21, CD11b, and For personal use only. on October 27, 2017. by guest www.bloodjournal.org From SB cells appears unlikely. Based on paradigms in the mature phopoiesis in the bone marrow microenvironment. If CD23 has a role in prevention of apoptosis in B-cell precursors, B-cell compartment, and parallels with early T-cell and myeloid development, a working hypothesis that the novel then CD23 might act independently to provide a rescue signal or, perhaps more likely, could act in synergy with other sCD23 receptor on SMS-SB cells acts to restrain apoptosis of the cells is attractive. In the majority of reports on sCD23 cytokines and adhesion strucutres to modulate the fate of Blymphoid progenitors. These issues will be resolved only activity, including the thymocyte 19 and centrocyte systems, 20 the effects of sCD23 are only observed after pretreatment when detailed knowledge of the CD23 receptor present on SMS-SB cells is available and the pattern of its expression of the cells with IL-1. In these systems, IL-1 may preactivate the cells, priming them to respond to a signal from sCD23;
in normal B-cell progenitors can be assessed.
The SMS-SB cell line provides a very useful model for the this may occur via induction or increase in number or affinity of CD23 receptors at the cell surface. In the germinal centre study of the novel sCD23/CD23 receptor whose existence is suggested by the data presented in this report; the cells will model, the requirement for IL-1 can be overcome by anti-CD21 MoAbs, a subset of which are capable of preventing be particularly useful in the analysis of mechanisms of CD23 action in the absence of other known receptors. The data centrocyte apoptosis. 37 However, no endogenous IL-1a or IL-1b activity is present in SMS-SB cell supernatants, and show that ligation of the novel CD23 receptor prevents apoptosis of SMS-SB cells and, once the nature of the recepexogenous cytokine, either alone or in combination with sCD23, has any effect on proliferation or prevention of tor is defined, it will be interesting to examine its expression and possible functions at different stages in the normal and apoptosis in SMS-SB cells (data not illustrated); sCD23 alone is sufficient to completely prevent apoptosis in SMSneoplastic development of B lymphocytes and other hematopoietic lineages. SB cells cultured at low cell density. The transformed state of SMS-SB cells may explain the absence of a requirement for IL-1, or other form of cellular preactivation, for the ex-
